Allena Pharmaceuticals Inc (NASDAQ:ALNA) Shorted Shares Increased 53.3% After Market Selling

April 17, 2018 - By Marie Mckinney

The stock of Allena Pharmaceuticals Inc (NASDAQ:ALNA) registered an increase of 53.3% in short interest. ALNA’s total short interest was 118,500 shares in April as published by FINRA. Its up 53.3% from 77,300 shares, reported previously. With 69,900 shares average volume, it will take short sellers 2 days to cover their ALNA’s short positions. The short interest to Allena Pharmaceuticals Inc’s float is 1.42%.

The stock increased 1.72% or $0.24 during the last trading session, reaching $13.92. About 71,316 shares traded. Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company has market cap of $287.98 million. The companyÂ’s lead product candidate includes ALLN-177, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It currently has negative earnings. It is also involved in developing ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases.

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: